{"id":268289,"date":"2022-06-13T17:00:32","date_gmt":"2022-06-13T11:30:32","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=268289"},"modified":"2022-06-22T16:52:13","modified_gmt":"2022-06-22T11:22:13","slug":"del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/","title":{"rendered":"Del HC grants ex-parte ad-interim injunction in trademark infringement of Glaxo’s BETNESOL and BETNOVATE"},"content":{"rendered":"

Delhi High Court<\/strong>: Jyoti Singh, J. granted ex-parte ad-interim injunction and remarked that stricter approach is required in cases of medicinal preparations and products since any confusion between the respective medicinal products is likely to have a disastrous effect on public health.<\/p>\n

The facts of the case are such that the plaintiff Company is a world renowned pharmaceuticals and consumer healthcare company having Indian Subsidiary, Glaxo Laboratories (India) being one of the market leaders in many therapeutic areas and in preventive healthcare in India. Since the early 1960s, Plaintiff is selling medicinal and pharmaceutical preparations, including tablets and injections, bearing one or more of Plaintiff\u2019s BETNESOL Marks in India treating a wide variety of diseases, including, but not limited to, allergies and inflammatory disorders. Plaintiff is the proprietor of a valid and subsisting registration for the marks BETNESOL and BETNOVATE respectively in Class 5. The defendant is a Company incorporated under the Companies Act, 1956, engaged in the manufacturing, marketing and sale of pharmaceutical and medicinal products, including, tablets and oral drops, bearing the marks BETNEZEN and BETNEZEN FORTE and injections bearing the marks BETNECOL and BETNEVIN. As per Plaintiff\u2019s information, Defendant\u2019s tablets, oral drops and injections bearing Defendant\u2019s Mark contain the active ingredient, Betamethasone and are used for the treatment of allergies and inflammatory disorders.<\/p>\n

The plaintiff sent a legal notice to the Defendant demanding that Defendant should cease any and all use of Defendant\u2019s Marks as it solely belong to the plaintiff\u2019s. No response was received but on the contrary, Defendant continues to use Defendant\u2019s Marks openly and blatantly. Thus, the instant application was preferred by the Plaintiff under Order 39 Rules 1 and 2 read with Section 151 of the Code of Civil Procedure 1908 i.e. CPC for grant of an ex-parte ad-interim injunction.<\/p>\n

Counsel for petitioner submitted that owing to long and continuous use of Plaintiff\u2019s BETNESOL Marks, consumers in India associate the marks solely and exclusively with the Plaintiff and no one else.<\/p>\n

It was averred that Plaintiff\u2019s and Defendant\u2019s Marks starts with the letter combination \u201cBETNE\u201d. Defendant has merely replaced the letter \u201cS\u201d with the letter \u201cC\u201d in Plaintiff\u2019s BETNESOL Marks to form Defendant\u2019s BETNECOL mark. Defendant has merely replaced the letter combinations \u201cSOL\u201d and \u201cOVATE\u201d in Plaintiff\u2019s BETNESOL Marks and Plaintiff\u2019s BETNOVATE Marks with the letter combination \u201cVIN\u201d and \u201cZEN\u201d to form the Defendant\u2019s BETNEVIN and BETNEZEN marks. Thus, the rival marks, when looked at in their entirety, are similar in appearance, sound, and structure creating chances of consumer confusion.<\/p>\n

The Court relied on Cadila Health Care<\/em> v. Cadila Pharmaceuticals<\/em>, (2001) 5 SCC 73<\/a> and observed that a stricter approach is required in cases of medicinal preparations and products since any confusion between the respective medicinal products is likely to have a disastrous effect on public health. Therefore, there is no doubt that Defendant\u2019s Marks are nearly identical\/similar to Plaintiff\u2019s Marks and are likely to cause confusion amongst the consuming public as to the source of the goods under the Defendant\u2019s Marks.<\/p>\n

The Court held \u201cPlaintiff has made out a prima facie case for grant of an ex parte ad-interim injunction. Balance of convenience lies in favour of the Plaintiff and it is likely to suffer irreparable harm in case the injunction, as prayed for, is not granted.\u201d [Glaxo Group Ltd. v. Zenlabs Ethica Ltd., <\/span><\/strong>2022 SCC OnLine Del 1772<\/b><\/a>, decided on 03-06-2022<\/span><\/strong>]<\/p>\n

\n

Appearances<\/p>\n

For petitioner- Mr. Urfee Roomi, Mr. Parth and Mr. Vishesh Kumar<\/p>\n

\n

*Arunima Bose, Editorial Assistant has reported this brief.<\/span><\/h4>\n","protected":false},"excerpt":{"rendered":"

Delhi High Court: Jyoti Singh, J. granted ex-parte ad-interim injunction and remarked that stricter approach is required in cases of medicinal preparations <\/p>\n","protected":false},"author":67011,"featured_media":268157,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[3,10],"tags":[49675,49676,44986,49678,3215,48798,49674,49677],"class_list":["post-268289","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-casebriefs","category-highcourts","tag-betnesol","tag-betnovate","tag-code-of-civil-procedure","tag-glaxo","tag-infringement","tag-pharmaceuticals","tag-registered-marks","tag-zenlabs"],"yoast_head":"\nDel HC grants ex-parte ad-interim injunction in trademark infringement of Glaxo's BETNESOL and BETNOVATE | SCC Times<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Del HC grants ex-parte ad-interim injunction in trademark infringement of Glaxo's BETNESOL and BETNOVATE\" \/>\n<meta property=\"og:description\" content=\"Delhi High Court: Jyoti Singh, J. granted ex-parte ad-interim injunction and remarked that stricter approach is required in cases of medicinal preparations\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-13T11:30:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-22T11:22:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/Delhi-HC.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1331\" \/>\n\t<meta property=\"og:image:height\" content=\"888\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/\",\"name\":\"Del HC grants ex-parte ad-interim injunction in trademark infringement of Glaxo's BETNESOL and BETNOVATE | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/Delhi-HC.jpg\",\"datePublished\":\"2022-06-13T11:30:32+00:00\",\"dateModified\":\"2022-06-22T11:22:13+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/Delhi-HC.jpg\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/Delhi-HC.jpg\",\"width\":1331,\"height\":888,\"caption\":\"Delhi High Court\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Del HC grants ex-parte ad-interim injunction in trademark infringement of Glaxo’s BETNESOL and BETNOVATE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Del HC grants ex-parte ad-interim injunction in trademark infringement of Glaxo's BETNESOL and BETNOVATE | SCC Times","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/","og_locale":"en_US","og_type":"article","og_title":"Del HC grants ex-parte ad-interim injunction in trademark infringement of Glaxo's BETNESOL and BETNOVATE","og_description":"Delhi High Court: Jyoti Singh, J. granted ex-parte ad-interim injunction and remarked that stricter approach is required in cases of medicinal preparations","og_url":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2022-06-13T11:30:32+00:00","article_modified_time":"2022-06-22T11:22:13+00:00","og_image":[{"width":1331,"height":888,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/Delhi-HC.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Editor","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/","url":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/","name":"Del HC grants ex-parte ad-interim injunction in trademark infringement of Glaxo's BETNESOL and BETNOVATE | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/Delhi-HC.jpg","datePublished":"2022-06-13T11:30:32+00:00","dateModified":"2022-06-22T11:22:13+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/Delhi-HC.jpg","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/Delhi-HC.jpg","width":1331,"height":888,"caption":"Delhi High Court"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/13\/del-hc-restrains-zenlabs-from-doing-any-act-that-amounts-to-infringement-of-glaxos-registered-marks-betnesol-and-betnovate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Del HC grants ex-parte ad-interim injunction in trademark infringement of Glaxo’s BETNESOL and BETNOVATE"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/Delhi-HC.jpg","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":292523,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/05\/18\/delhi-high-court-restrains-biogen-serums-from-using-product-using-betnol-marks-being-similar-to-glaxo-group-betnesol-legal-updates\/","url_meta":{"origin":268289,"position":0},"title":"[Betnesol v Betnol]: Delhi High Court grants permanent injunction in favour of Glaxo Group Limited on failure to file written statement by Biogen Serums","author":"Arunima","date":"May 18, 2023","format":false,"excerpt":"Delhi High Court observed that the defendant has used the infringing mark \u2018BETNOL\u2019, which is identical to the plaintiff's mark \u2018BETNESOL\u2019 with the intent to springboard its business by drawing association with the plaintiff and its trademark to ride on the goodwill and reputation of the mark of the plaintiff.","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"delhi high court","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/delhi-high-court.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/delhi-high-court.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/delhi-high-court.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/delhi-high-court.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":298498,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/08\/04\/delhi-hc-grants-injunction-to-glaxo-group-for-its-various-marks-legal-news\/","url_meta":{"origin":268289,"position":1},"title":"Delhi High Court grants injunction in favour of Glaxo Group for its marks Betnovate-N, Betnovate-C, T-Bact, Cobadex, Zentel, Augmentin","author":"Simranjeet","date":"August 4, 2023","format":false,"excerpt":"\u201cThe comparison of the defendant's and the plaintiffs\u2019 marks will show that the defendant has not merely copied one mark or packaging but has deliberately adopted a series of marks, in packaging with almost identical colour combinations.\u201d","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"delhi high court","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":277941,"url":"https:\/\/www.scconline.com\/blog\/post\/2022\/11\/23\/delhi-high-court-confirms-ad-interim-ex-parte-order-of-injunction-passed-in-favour-of-sun-pharmaceutical-industries-ltd-for-its-mark-forzest-cost-of-rs-10-lakhs-imposed-for-concealing\/","url_meta":{"origin":268289,"position":2},"title":"Delhi High Court confirms ad-interim ex-parte order of injunction passed in favour of Sun Pharmaceutical Industries Ltd. for its mark \u2018FORZEST\u2019; Cost of Rs. 10 lakhs imposed for concealing material facts","author":"Editor","date":"November 23, 2022","format":false,"excerpt":"\u00a0 \u00a0 Delhi High Court: In a trade mark infringement case where the ex-parte ad-interim order of injunction was challenged, the Single Judge Bench of Navin Chawla, J. confirmed the order of injunction passed by this Court in favour of Sun Pharmaceutical Industries Ltd., and imposed Rs. 10,00,000 costs on\u2026","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"Delhi High Court","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/07\/delhi_high_court.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/07\/delhi_high_court.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/07\/delhi_high_court.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/07\/delhi_high_court.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/07\/delhi_high_court.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":324619,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/06\/18\/bhc-grants-ad-interim-injunction-to-glenmark-pharmaceuticals-for-mark-zitamet\/","url_meta":{"origin":268289,"position":3},"title":"\u2018Ordinary common man will be confused\u2019; Bombay HC grants ad-interim injunction to Glenmark Pharmaceuticals for mark \u201cZITA-MET\u201d against Gleck Pharma\u2019s mark \u201cXIGAMET\u201d","author":"Simranjeet","date":"June 18, 2024","format":false,"excerpt":"The Court stated that physicians, doctors, and chemists are knowledgeable in their field, however they are not infallible, and in respect of medicinal and pharmaceutical products there cannot be any leeway for mistakes, since even a possibility of a mistake may prove fatal to the consumers.","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"Bombay High Court","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Bombay-High-Court.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Bombay-High-Court.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Bombay-High-Court.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Bombay-High-Court.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":340573,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/02\/06\/dhc-grants-ad-interim-injunction-to-leading-pharmaceutical-company-novartis-restrains-use-of-novitas-mark\/","url_meta":{"origin":268289,"position":4},"title":"Delhi High Court grants ad interim injunction to leading pharmaceutical company NOVARTIS; restrains use of NOVITAS mark","author":"Arushi","date":"February 6, 2025","format":false,"excerpt":"The plaintiffs submitted that the confusingly similar trade mark in the field of pharmaceuticals, create greater injury as compared to products and services in other fields.","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"Delhi High Court","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Delhi-High-Court.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Delhi-High-Court.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Delhi-High-Court.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Delhi-High-Court.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":278667,"url":"https:\/\/www.scconline.com\/blog\/post\/2022\/11\/21\/delhi-high-court-grants-ex-parte-ad-interim-injunction-to-american-eagle-against-ektarfa-garments-in-a-trademark-and-copyright-infringement-suit\/","url_meta":{"origin":268289,"position":5},"title":"Delhi High Court grants ex-parte ad-interim injunction to American Eagle against Ektarfa Garments in a trademark and copyright infringement suit","author":"Editor","date":"November 21, 2022","format":false,"excerpt":"\u00a0 \u00a0 Delhi High Court: In a case where application was filed under Order 39 Rules 1 and 2 read with Section 51 of the Civil Procedure Code, 1908 (Code) in a trademark and copyright infringement suit, the Single Judge Bench of Jyoti Singh, J. Passed an Order granting ex-parte\u2026","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"Delhi High Court","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/07\/delhi_high_court.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/07\/delhi_high_court.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/07\/delhi_high_court.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/07\/delhi_high_court.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/07\/delhi_high_court.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/268289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=268289"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/268289\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/268157"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=268289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=268289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=268289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}